BREWIN DOLPHIN LTD - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 127 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$18,617
-32.8%
3,7160.0%0.00%0.0%
Q2 2021$27,721
+49.0%
3,716
+17.2%
0.00%0.0%
Q1 2021$18,608
+101.0%
3,170
+60.9%
0.00%0.0%
Q4 2020$9,2591,9700.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Baker Brothers Advisors 23,222,222$181,133,3322.32%
Anson Funds Management LP 941,908$7,346,8820.88%
QVT Financial LP 575,705$4,490,4990.42%
Wealth Management Partners, LLC 42,000$327,6000.16%
Pinpoint Asset Management Ltd 120,746$941,8190.13%
VANCE WEALTH, INC. 39,266$306,2750.13%
Sargent Investment Group, LLC 72,000$561,6000.12%
China Universal Asset Management Co., Ltd. 82,473$643,2890.09%
Caption Management, LLC 723,700$5,644,8600.09%
SECTORAL ASSET MANAGEMENT INC 25,000$195,0000.08%
View complete list of SUMMIT THERAPEUTICS INC shareholders